Skip to Content
Quarter-End Insights

Economic Outlook: We Remain Optimistic for a Rapid Recovery

A lot is riding on the coronavirus vaccine.

In the past six months, consensus expectations have essentially converged to our optimistic view on the U.S. economic recovery. We expect U.S. GDP to drop 3.4% in 2020 but surge back in 2021 and experience further catch-up growth in following years. By 2024, we think that U.S. GDP will recover to just 1% below our pre-COVID-19 expectation.

U.S. GDP will fall sharply in 2020, but we expect rapid catch-up afterwards - Morningstar

Widespread vaccination in the U.S. by mid-2021 should enable a return to normal in much of the economy. In industries highest affected by COVID-19 (such as restaurants and hotels), employment and output were down 15%-20% year over year in the third quarter. These industries account for just 6% of U.S. GDP at prepandemic levels but 15% of employment. As such, their recovery is critical for a broader labor market recovery. U.S. consumers are eager to spend, as evinced by very strong spending on consumer goods, especially durables. Consumer-services spending should come roaring back once the need for social distancing is alleviated by mass vaccination.

U.S. consumers are eager to spend - Morningstar

The passage of a new $900 billion (about 4% of U.S. GDP) stimulus package has removed one concern regarding the U.S. economy. But we don't think a lack of stimulus would have been fatal to the recovery. Another potential threat is the surge in coronavirus cases in recent months; however, we don't think this will sink the economy before the vaccine can be rolled out. Additionally, we don't see major macroeconomic implications from the U.S. election outcome, irrespective of whether the Democrats capture the Senate via the Jan. 5 Georgia runoffs. 

We've looked at several historical episodes in order to best understand the world after COVID-19. Our goal is to understand, in general, what happens when the economy is perturbed by an extreme but temporary external shock. Pandemics are one type of this class of events, but so also are wars, political upheaval, and related disruptions. For example, our analysis shows that U.K. rationing in World War II didn't depress long-run consumption of rationed goods via a change in habits. Instead, demand for rationed goods generally mounted a full recovery. Episodes like this suggest we should think carefully before proclaiming that any aspect of pandemic life will become the "new normal."

WWII rationing had little long-term impact on U.K. food demand - Morningstar

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.